IRON stock news · Disc Medicine
Get alerts for IRON
Follow Disc Medicine (IRON) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IRON12 health care companies are seeing big changes in their stock prices today.
NeutralThe article reports a rise in Disc Medicine shares but gives no company news explaining it. The share move alone does not change what the article says about the company.
Disc Medicine shows hope for people with sunlight sensitivity after a successful study.
Good for IRONDisc Medicine reported that bitopertin met all goals in a Phase 3 study and helped patients spend more time in light without pain. This supports the company's approval effort.
Silence Therapeutics, Disc Medicine, Veradermics, and other major stocks jumped up on Monday.
Good for IRONDisc Medicine reported that its Phase 3 trial met its primary and secondary endpoints, including in X-linked protoporphyria. Those results support a favorable outlook for its drug program.
12 health care stocks are changing a lot before the market opens on Monday.
NeutralThe story reports a sharp pre-market rise in Disc Medicine shares but gives no reason or company update, so it does not change the company's business outlook.
Disc Medicine, Inc. shares important news about their drug trial results.
Good for IRONDisc Medicine reported that bitopertin met every APOLLO Phase 3 endpoint. This strongly improves its outlook, though FDA approval is still ahead.